KEFAMAST DRY COW, intramaminė suspensija karvėms
KEFAMAST DRY COW, intramaminė suspensija karvėms
Not authorised
- Dihydrostreptomycin
- Cefalexin
Product identification
Medicine name:
KEFAMAST DRY COW, intramaminė suspensija karvėms
Active substance:
- Dihydrostreptomycin
- Cefalexin
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Dihydrostreptomycin500.00/milligram(s)1.00Syringe
-
Cefalexin500.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Meat and offal28day
-
Milk3dayIf the cow calves less than 40 days later. after treatment for milk - 42.5 days
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Lithuania
Package description:
- Polietileniniai švirkštai po 10 ml (9 g) intramaminės suspensijos, kibirėliuose po 120 vnt.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Bimeda Animal Health Limited
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/98/0723/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV0723.pdf
Lithuanian (PDF)
Download Published on: 1/06/2022
